You are here: Industry Insights > china

News List

Ping An announces $150M Equity Investment in GDS biospectrumasia
March 15, 2019
China Ping An Insurance Overseas (Holdings) Limited, a subsidiary of Ping An Insurance (Group) Company of China, Ltd. (Ping An), has announced a US$150 million equity investment in GDS Holdings Limited, a leading developer and operator of high-performance
SPARC inks research collaboration pact with China’s HitGen expressbpd
March 14, 2019
Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments
Medtec China 2019 swells up by 21% biospectrumasia
March 13, 2019
Medtec China 2019 will be held September 25-27. There will be a grand 15th anniversary celebration and opening ceremony, business matchmaking service, and many more appealing events
CStone received IND approval in China for HDAC6 inhibitor CS3003 en-cphi.cn
March 13, 2019
Cstone announced that the National Medical Products Administration (NMPA) recently approved company's histone deacetylase 6 (HDAC6) selective inhibitor CS3003 for Phase I clinical trial in China.
China moves to expand cancer medicine access biospectrumasia
March 11, 2019
Last October, the prices of 17 cancer drugs were slashed by an average of 56.7 percent following negotiations with drugmakers.
Sanofi appoints New General Manager China biospectrumasia
March 04, 2019
Hornstein was the General Manager and Country Chair of Sanofi Brazil for the last four years.
Approved by NMPA! Dulaglutide, Eli Lilly’s Quality Hypoglycemic Drug that Reached USD3.2 Billion Sales Last Year, to be Marketed in China PharmaSources/Caicai
March 04, 2019
To Surpass Hansoh’s Loxenatide?
Bio-macromolecular Drugs in the Autoimmune Disease Field in China PharmaSources/1℃
February 13, 2019
Focus on the bio-macromolecular drugs in the autoimmune disease field that have been marketed or in the marketing review stage in China, overall, including 9 marketed drugs and 6 drugs in the marketing review.
Lunar New Year focuses on traditional chinese medicine for cancer treatment biospectrumasia
February 11, 2019
Research reveals nearly half of Singaporeans combine potentially dangerous cocktail of Chinese and Western medicine during cancer treatment
To Accelerate Linking up with the International Standards, China Making Efforts to Join PIC/S, Another World-class Organization PharmaSources/Dishui Sinan
January 30, 2019
The “Work Plan for 2019” of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) was fresh out on Jan. 1, 2019, and the news “China will Join PIC/S, Another World-class Organization...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page